Orally active NGF synthesis stimulators: Potential therapeutic agents in Alzheimer's disease

Behavioural Brain Research

Volumn 83, Issue 1-2, 1997, Pages 117-122

  Yamada, Kiyofumi ^a   Nitta, Atsumi ^a,c   Hasegawa, Takaaki ^a   Fuji, Kazuyuki ^b   Hiramatsu, Masayuki ^b   Kameyama, Tsutomu ^b   Furukawa, Yoshiko ^c   Hayashi, Kyozo ^c   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

aged rat; Alzheimer's disease; basal forebrain; idebenone; learning and memory; nerve growth factor; propentofylline

Indexed keywords

CHOLINE ACETYLTRANSFERASE; IDEBENONE; NERVE GROWTH FACTOR; PROPENTOFYLLINE; QUINUCLIDINYL BENZILATE;

ADOLESCENT; AGING; ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD BRAIN BARRIER; CONFERENCE PAPER; CONTROLLED STUDY; LEARNING; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0031081164     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)86054-8     Document Type: Conference Paper

References (32)

1. [1] Anezaki, T., Yanagisawa, K., Takahashi, H., Nakajima, T., Miyashita, K., Ishihara, A., Ikuta, F. and Miyatake, T., Remote astrocytic response of prefrontal cortex is caused by the lesion in the nucleus basalis of Meynert, but not in the ventral tegmental area, Brain Res., 574 (1992) 63-69.
2. [2] Bakhit, C., Armanini, M., Bennett, G.L., Wong, W.L.T., Hansen, S.E. and Taylor, R., Increase in glia-derived nerve growth factor following destruction of hippocampal neurons, Brain Res., 560 (1991) 76-83.
3. [3] Bartus, R.T., Dean, R.L., Beer, B. and Lippa, A.S., The cholinergic hypothesis of geriatric memory dysfunction, Science, 217 (1982) 408-417.
4. [4] Coyle, J.T., Price, D.L. and Delong, M.R., Alzheimer disease: a disorder of cortical cholinergic innervation, Science, 219 (1983) 1184-1190.
5. [5] Delacourte, A., General and dramatic glial reaction in Alzheimer brains, Neurology, 40 (1990) 33-37.
6. [6] Fuji, K., Hiramatsu, M., Kameyama, T. and Nabeshima, T., Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats, Eur. J. Pharmacol., 236 (1993) 411-417.
7. [7] Furukawa, S., Kamo, I., Furukawa, Y., Akazawa, S., Satoyoshi, E., Itoh, K. and Hayashi, K., A highly sensitive enzyme immunoassay for mouse β nerve growth factor, J. Neurochem., 40 (1983) 734-744.
8. [8] Gnahn, H., Hefti, F., Heumann, R., Schwab, M.E. and Thoenen, H., NGF mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for physiological role of NGF in the brain? Dev. Brain Res., 9 (1983) 305-311.
9. [9] Hefti, F., Nerve growth factor promotes survival of septal cholinergic neurons after flmbrial transections, J. Neurosci., 6 (1986) 2155-2162.
10. [10] Honegger, P. and Lenoir, D., Nerve growth factor (NGF) stimulation of cholinergic telencephalic neurons in aggregating cell culture, Dev. Brain Res., 3 (1982) 229-238.
11. [11] MacDonald, C.M., Gerbert, U., Stevens, L.A. and Omosu, M., Whole body autoradiographic quantitative tissue distribution and multiple dose tissue residue studies on HWA 285 in the rat, Pharmacol. Ther., 14 (1986) 2001-2012.
12. [12] Miyamoto, M., Murphy, T.H., Schnaar, R.L. and Coyle, J.T., Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line, J. Pharmacol. Exp. Ther., 250 (1989) 1132-1140.
13. [13] Morris, R.G.M., Development of water-maze procedure for studying spatial learning in the rat, J. Neurosci. Methods, 11 (1984) 47-60.
14. [14] Murase, K., Nabeshima, T., Robitaille, Y., Quirion, R., Ogawa, M. and Hayashi, K., NGF level is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease, Biochem. Biophys. Res. Commun., 193 (1993) 198-203.
15. [15] Nabeshima, T., Nitta, A. and Hasegawa, T., Impairment of learning and memory and the accessory symptom in aged rats as senile dementia model (3): oral administration of propentofylline produces recovery of reduced NGF content in the brain of aged rats, Jpn. J. Psychopharmacol., 13 (1993) 89-95.
16. [16] Nabeshima, T., Nitta, A., Fuji, K., Kameyama, T. and Hasegawa, T., Oral administration of NGF synthesis stimulators recovers reduced brain NGF content in aged rats and cognitive dysfunction in basal-forebrain-lesioned rats, Gerontology, 40 (1994) 46-56.
17. [17] Nabeshima, T, Ogiwara, Y., Nitta, A., Onishi, J. and Noda, Y., Effects of propentofylline, a nerve growth factor synthesis stimulator, on cholinergic dysfunction induced by infusion of anti-NGF antibody into rat's septum, Soc. Neurosci. Abstr., 21 (1995) 949.
18. [18] Nitta, A., Hasegawa, T. and Nabeshima, T., Oral administration of idebenone, a stimulator of NGF synthesis, recovers reduced NGF content in aged rat brain, Neurosci. Lett., 163 (1993) 219-222.
19. [19] Nitta, A., Murase, K., Furukawa, Y., Hayashi, K., Hasegawa, T. and Nabeshima, T., Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats, Eur. J. Pharmacol., 250 (1993) 23-30.
20. [20] Nitta, A., Murase, K., Furukawa, Y., Hayashi, K., Hasegawa, T. and Nabeshima, T., Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats, Neuroscience, 57 (1993) 495-499.
21. [21] Nitta, A., Murase, K., Furukawa, Y., Kawatsura, W., Hayashi, K., Yamada, K., Hasegawa, T. and Nabeshima, T., Oral administration of idebenone induces nerve growth factor in the brain and improves learning and memory in basal forebrain-lesioned rats, Naunyn-Schmiedeberg's Arch. Pharmacol., 349 (1994) 401-407.
22. [22] Nonaka, R. and Moroji, T., Quantitative autoradiography of muscarinic cholinergic receptors in the rat brain, Brain Res., 296 (1984) 295-303.
23. [23] Ogawa, S., Nabeshima, T., Kameyama, T. and Hayashi, K., Effects of nerve growth factor (NGF) in rats with basal forebrain lesions, Jpn. J. Pharmacol., 61 (1993) 141-144.
24. [24] Ogihara, Y., Nitta, A., Onishi, J., Hasegawa, T. and Nabeshima, T., Oral administration of propentofylline, a stimulator for nerve growth factor (NGF) synthesis, recovers cholinergic neuronal dysfunction induced by the infusion of anti-NGF antibody into rat's septum, Jpn. J. Pharmacol., Suppl. I, 67 (1995) 204P.
25. [25] Olson, L., Nordberg, A., von Holst, H., Bäckmann, L., Edendal, T., Alafusoff, I., Amberla, K., Hartvig, P., Herlitz, A., Lilja, A., Lundqvist, H., Längström, B., Meyerson, B., Persson, A., Viitanen, M., Winblad, B. and Seiger, A., Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in Alzheimer patient (case report), J. Neural Transm. Park. Dis. Dement. Sec., 4 (1992) 79-95.
26. [26] Onishi, J., Nitta, A., Ogihara, Y., Hasegawa, T. and Nabeshima, T., Oral administration of idebenone, a stimulator for nerve growth factor (NGF) synthesis, ameliorates cholinergic neuronal dysfunction induced by the infusion of anti-NGF antibody into rat's septum, Jpn. J. Pharmacol., Suppl. I, 67 (1995) 204P.
27. [27] Platel, A. and Porsolt, R.D., Habituation of exploratory activity in mice: a screening test for memory enhancing drugs, Psychopharmacology, 78 (1982) 346-352.
28. [28] Shinoda, I., Furukawa, Y. and Furukawa, S., Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells, Biochem. Pharmacol., 39 (1990) 1813-1816.
29. [29] Takeuchi, R., Murase, K., Furukawa, Y., Furukawa, S. and Hayashi, K., Stimulation of nerve growth factor synthesis/secretion by 1,4-benzoquinone and its derivatives in cultured mouse astroglia, FEBS Lett., 261 (1990) 63-66.
30. [30] Torii, H., Yoshida, K., Kobayashi, T., Tsukamoto, T. and Tanayama, S., Disposition of idebenone (CV-2619), a new cerebral metabolism improving agent, in rats and dogs, J. Pharmacobiodyn., 8 (1985) 457-467.
31. [31] Williams, L.R., Varon, S., Peterson, G.M., Wilctorin, K., Fischer, W., Bjorklund, A. and Gage, H.G., Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection, Proc. Natl. Acad. Sci. USA, 83 (1986) 9231-9235.
32. [32] Wu, P.H., Barraco, R.A. and Phillis, J.W., Further studies on the inhibition of adenosine uptake into rat brain synaptosomes by adenosine derivatives and methyl xanthines, Gen. Pharmacol., 15 (1984) 251-254.